🔗 Share this article

A shadow market for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.

Experimental Treatment Gaining Traction Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are encouraged to contact these accounts privately for supplier links, while also receiving discount codes.

Active Trade on Social Networks

Separately, a robust trade exists on messaging services, where communities with thousands of members share “before and after” images, administration instructions and claims of rapid UK delivery. Vendors market the drug there before directing customers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

However, doctors and pharmacists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals administering products of unknown origin.

Several professionals said the popularity for retatrutide could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.

Legal Position and Implementation

Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the British medical regulations.

Some influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach medicines, marketing, and customer laws, risking fines, legal action or prison.

Service Response and Content Elimination

According to TikTok, the platform has taken down problematic material and banned related hashtags and query recommendations. The organization stated it was committed to maintaining the service safe and investing in enhancing enforcement strategies.

Online Marketplace Activities

Research also found communities with up to 9,000 members selling retatrutide using the platform's integrated search feature, which functions like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of users, populated with images of slimming results, positive reviews and step-by-step guides for preparing or administering at residence.

After moments of joining one group, a seller posted WhatsApp details, where the majority of purchases occur. The seller sent an guidebook and promised delivery within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about body mass, health issues or past usage.

Item Details and Pricing

Inside these groups, posts display black plastic parcels with postal service labels, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with sterile water, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When asked how much time a injector should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for Telegram stated it regularly monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering materials they can’t verify. Even if the science behind retatrutide is valid, these digital versions may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the surge in demand to current price rises for authorized slimming medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.

Her staff has already encountered individuals harmed by personal administration from unverified sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Producer Statement

A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose patients to potentially serious health risks”.